Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AminoMedixTM for Radiation Kidney Protection During Peptide-Receptor Radionuclide Therapy (PRRT): Phase I, II Clinical Trial

NCT05785663 is registered in ClinicalTrials.gov with Excel Diagnostics and Nuclear Oncology Center as lead sponsor.

NCT NCT05785663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05785663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AminoMedixTM for Radiation Kidney Protection During Peptide-Receptor Radionuclide Therapy (PRRT): Phase I, II Clinical Trial
Lead sponsor
Excel Diagnostics and Nuclear Oncology Center
Phase
Observational
Overall status
Completed
Start date
August 8, 2014
Completion date
March 17, 2020
Enrollment
28 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

radiation nephropathy